I. Valéa

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
I Valea, I. Valea, Innocent Valea, Innocent Valéa
Publication record
138 papers · 4,798 citations · H-index 30

PAPERS

Postpartum cytokine shifts and IL-10–mediated immune suppression in malaria-infected primigravid women
20260 citationsauthor #5
The clinical significance of monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratios in malaria infection and parasitaemia among pregnant women in Nanoro, Burkina Faso.
20250 citationsauthor #19
Postpartum cytokine shifts and IL-10–mediated immune suppression in malaria-infected primigravid women
20250 citationsauthor #5
Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020–2021
20250 citationsauthor #30
Sulfadoxine–pyrimethamine alone or with azithromycin for the intermittent preventive treatment of malaria in pregnancy: protocol for a systematic review and meta-analysis
20250 citationsauthor #4
Effects of gestational age on blood cortisol and prolactin levels during pregnancy in malaria endemic area
20240 citationsauthor #10
Prevalence and determinants of anaemia among pregnant women in a high malaria transmission setting: a cross-sectional study in rural Burkina Faso
20245 citationsauthor #3
Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen
20240 citationsauthor #7
Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections
20242 citationsauthor #5
Phytochemical Analysis and Antimicrobial Activity of Lawsonia inermis Leaf Extracts from Burkina Faso
20248 citationsauthor #10
OA-58 Associations between prenatal malaria exposure, maternal antibodies at birth and malaria susceptibility during the first year of life in Burkina Faso
20231 citationsauthor #11
Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso
20238 citationsauthor #11
Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
20238 citationsauthor #3
Correction: Performance of PfHRP2‑RDT for malaria diagnosis during the first year of life in a high malaria transmission area in Burkina Faso
20230 citationsauthor #10
Performance of PfHRP2-RDT for malaria diagnosis during the first year of life in a high malaria transmission area in Burkina Faso
20234 citationsauthor #10
PA-569 Evaluation of the effect of intermittent preventive treatment of malaria in pregnancy five years after the update of the national policy in Burkina Faso
20230 citationsauthor #4
Factors affecting African postdoctoral researcher capacity development within ‘learn-by-doing’ international research partnerships: findings from the ‘Partnership for Increasing the Impact of Vector Control (PIIVeC)’
20233 citationsauthor #2
Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis
20236 citationsauthor #57
PA-216 Contribution of next generation sequencing (NGS) tools for molecular surveillance of malaria drug resistance markers in Burkina Faso
20230 citationsauthor #9
Creating a best practice template for participant communication plans in global health clinical studies
20233 citationsauthor #7
Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen
20231 citationsauthor #8
Fetal sex and risk of pregnancy-associated malaria in Plasmodium falciparum-endemic regions: a meta-analysis
20232 citationsauthor #6
Plasmodium falciparum sexual conversion rates can be affected by artemisinin-based treatment in naturally infected malaria patients
202212 citationsauthor #8
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial.
2022160 citationsauthor #24
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data
20229 citationsauthor #135
Age-modified factors associated with placental malaria in rural Burkina Faso
202212 citationsauthor #4
Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
20224 citationsauthor #13
Prevalence and risk factors of malaria among first antenatal care attendees in rural Burkina Faso
20227 citationsauthor #3
Low birth weight and its associated risk factors in a rural health district of Burkina Faso: a cross sectional study
202212 citationsauthor #3
Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
20223 citationsauthor #8
Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial [version 2; peer review: 2 approved]
20210 citationsauthor #2
Magnitude of low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso: a secondary data analysis
20212 citationsauthor #3
Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
202113 citationsauthor #15
Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
202166 citationsauthor #17
Malaria and curable sexually transmitted and reproductive tract coinfection among pregnant women in rural Burkina Faso
20214 citationsauthor #3
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
20210 citationsauthor #9
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
20216 citationsauthor #9
[Polymorphisms in Plasmodium falciparum parasites and mutations in the resistance genes Pfcrt and Pfmdr1 in Nanoro area, Burkina Faso].
20211 citationsauthor #10
Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso
20212 citationsauthor #8
High Efficacy of a Low Dose Candidate Malaria Vaccine, R21 in 1 Adjuvant Matrix-M™, with Seasonal Administration to Children in Burkina Faso
202116 citationsauthor #27
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
2021253 citationsauthor #27
Plasmodium falciparum gametocyte carriage in symptomatic patients shows significant association with genetically diverse infections, anaemia, and asexual stage density
202111 citationsauthor #9
Association of malaria and curable sexually transmitted infections with pregnancy outcomes in rural Burkina Faso
20213 citationsauthor #3
Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso
202110 citationsauthor #8
Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS)
20217 citationsauthor #3
Spatial patterns of child mortality in Nanoro HDSS site, Burkina Faso
20200 citationsauthor #3
Cardiovascular safety and population pharmacokinetic properties of piperaquine in African patients with uncomplicated falciparum malaria – a pooled multicentre analysis
20200 citationsauthor #11
Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum Malaria
202010 citationsauthor #11
Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis
202029 citationsauthor #6
In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
202022 citationsauthor #5
Extending the reach of Seasonal Malaria Chemoprevention in Sub-Saharan Africa: A microplanning model to improve door-to-door health service delivery
20200 citationsauthor #3
A microplanning model to improve door-to-door health service delivery: the case of Seasonal Malaria Chemoprevention in Sub-Saharan African villages
20206 citationsauthor #4
Maternal factors of newborn low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso
20200 citationsauthor #3
Malaria and curable sexually transmitted infections in pregnant women: A two-years observational study in rural Burkina Faso
202010 citationsauthor #3
Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
202021 citationsauthor #36
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis
202027 citationsauthor #35
First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age
202010 citationsauthor #10
Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial
20205 citationsauthor #1
Fetal biometry assessment with Intergrowth 21st’s and Salomon’s equations in rural Burkina Faso
20207 citationsauthor #4
Assessment of the performance of malaria rapid diagnostic test in acutely malnourished children under five years of age in Nanoro - Burkina Faso
20203 citationsauthor #4
Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso
202013 citationsauthor #9
Clinical Management and Mortality among COVID-19 Cases in Sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case data analysis
20205 citationsauthor #7
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data
202040 citationsauthor #25
Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
202054 citationsauthor #9
Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans
201954 citationsauthor #8
high adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, nanoro, Burkina Faso
20190 citationsauthor #9
Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial
20191 citationsauthor #2
Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
201918 citationsauthor #34
The assessment of gestational age: a comparison of different methods from a malaria pregnancy cohort in sub-Saharan Africa
201937 citationsauthor #6
Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study
201916 citationsauthor #8
high adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, nanoro, Burkina Faso
20190 citationsauthor #9
A pooled analysis of the duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine
20192 citationsauthor #25
High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
20197 citationsauthor #9
Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial.
201945 citationsauthor #7
high adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, nanoro, Burkina Faso
20190 citationsauthor #9
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
201959 citationsauthor #17
Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study
201828 citationsauthor #8
Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial
201836 citationsauthor #13
Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study
201817 citationsauthor #2
In Vivo Antiplasmodial Activity of Two Sahelian Plant Extracts on Plasmodium berghei ANKA Infected NMRI Mice
201810 citationsauthor #6
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
20180 citationsauthor #56
Additional Screening and Treatment of Malaria During Pregnancy Provides Further Protection Against Malaria and Nonmalarial Fevers During the First Year of Life
20189 citationsauthor #11
Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections
201810 citationsauthor #20
Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial
201816 citationsauthor #1
Electronic Supplementary Material for: "Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections"
201819 citationsauthor #20
Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life
201831 citationsauthor #11
Profile of drug use during pregnancy at peripheral health centres in Burkina Faso
20181 citationsauthor #2
Low Birth Weight and Prematurity in Teenage Mothers in Rural Areas of Burkina Faso
201713 citationsauthor #10
Evaluation of Malaria Screening during Pregnancy with Rapid Diagnostic Tests Performed by Community Health Workers in Burkina Faso.
201723 citationsauthor #9
Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data
201753 citationsauthor #5
Evaluation of Malaria Screening during Pregnancy with Rapid Diagnostic Tests Performed by Community Health Workers in Burkina Faso
20170 citationsauthor #9
Comparison of effectiveness of two different artemisinin-based combination therapies in an area with high seasonal transmission of malaria in Burkina Faso
20172 citationsauthor #6
Evaluation of malaria screening during pregnancy with rapid 1 diagnostic tests performed by community health workers in Burkina 2 Faso, West Africa 3
20170 citationsauthor #10
First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies
201766 citationsauthor #17
Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countries
201629 citationsauthor #17
Selection of Plasmodium falciparum Pfmdr-1 N86Y alleles by Amodiaquine-Artesunate and Artemether-Lumefantrine in Nanoro, Burkina Faso
20161 citationsauthor #8
Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
201650 citationsauthor #6
Four artemisinin-based treatments in African pregnant women with malaria.
201685 citationsauthor #6
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms
201617 citationsauthor #15
Lessons learnt from 20 years surveillance of malaria drug resistance prior to the policy change in Burkina Faso.
20162 citationsauthor #2

TIMELINE

2004 76 citations

2005 42 citations

2009 175 citations

2010 27 citations

2011 664 citations

2012 929 citations

2013 38 citations

2014 172 citations

2015 808 citations

2016 380 citations

2017 157 citations

2018 177 citations

2019 239 citations

2020 262 citations

2021 394 citations

2022 219 citations

2023 36 citations

2024 15 citations

2025 0 citations

2026 0 citations

I. Valéa

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT